Litigation support services - foia

Ended Awarded Last action

Contract number
75F40122F19210
Awardee
Awarding agency
Obligated
$3,993,612

Award facts

Contract value 95% obligated
$4,195,773.50 Current and potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Contracting staff
Set-aside
Competitive 8(a)
Competition
Full and Open Competition Multiple Award, Fair Opportunity
Pricing
Labor Hours
Place of performance
Silver Spring, MD 20993, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00008 -$1,849,842
Other Administrative Action P00007 · Litigation support services foia against BPA no. HHSF223201810005B (requisition 1273021) $1,979,447
Other Administrative Action P00006 · Change CS $0
Other Administrative Action P00005 · Extend the POP dates and increase the LOE $430,378
Exercise an Option P00004 $1,162,394
Other Administrative Action P00003 $0
Funding Only Action P00002 · Add ODC line item for travel $3,000
Exercise an Option P00001 $1,701,176
Original award $567,059

About this award

The Food and Drug Administration issued a BPA call to Brillient Corporation under the GSA Multiple Award Schedule (MAS) for litigation support services related to Freedom of Information Act requests, with a ceiling value of $4,195,773.50, awarded April 4, 2022. The call is set aside for Competitive 8(a). Place of performance is Silver Spring, Maryland. Ultimate completion is August 19, 2026. Work is priced on a labor-hours basis.

Service Contract Inventory data shows government-invoiced labor of $458,000 across 3.0 FTEs in FY2022, growing to $1.3 million across 8.5 FTEs in FY2023 and $2.3 million across 16.6 FTEs in FY2024, representing year-over-year growth. Derived government-paid hourly rates declined from $73.29 per hour in FY2022 to $66.74 per hour in FY2024. In FY2024, one subcontractor performed 23 percent of contractor hours.

Quick answers

Who was awarded contract 75F40122F19210?

75F40122F19210 was awarded to Brillient Corporation by Food and Drug Administration (Department of Health and Human Services) on April 4, 2022.

How much is contract 75F40122F19210 worth?

The government has obligated $3,993,612 on 75F40122F19210. Its current value, with exercised options, is $4,195,774.

Is contract 75F40122F19210 an order under another contract?

Yes. 75F40122F19210 is a BPA call under GS00F012BA-HHSF223201810005B, a blanket purchase agreement, on Multiple Award Schedule (MAS).

Was contract 75F40122F19210 competed?

The extent of competition for 75F40122F19210 was full and open competition. It was set aside: Competitive 8(a).

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award